CypCaps
Pre-clinical- Indications
- Locally advanced, inoperable pancreatic cancer
Company intelligence / Profile preview
Beta-O2 Technologies
Rosh HaAyin*, Central District?*, Israelfinder.startupnationcentral.org ↗
- Ownership
- Private
- Employees
- ~35
- Development stage
- Preclinical
01
Overview
The company has demonstrated strong preclinical evidence of safe operation and functionality in animal models with its second-generation ßAir device. The device has shown reproducible insulin production from human pancreatic islet cells implanted within it without requiring immunosuppressive drugs. Human clinical trials are planned imminently following these promising results[2][6].
- Therapeutic areas
- Endocrinology
- Modalities
- Implantable bioreactor devicesBio-artificial pancreas technologyCell encapsulation technology involving pancreatic islets or stem cell-derived islets
- Industry
- Implantable Medical Devices
02
Drug pipeline
1 asset03
Partnerships
collaborations with U.S.-based pharmaceutical companies and academic institutions such as Harvard University, MIT, University of Virginia, Cornell Universitynegotiating collaborations with stem cell providers[6]
Beyond the preview
Go deeper on Beta-O2 Technologies.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Beta-O2 Technologies.